House Committees to Investigate New Alzheimer's Drug Approval

THURSDAY, July 1, 2021 (Healthday News) — The U.S. Food and Drug Administration’s controversial approval of a new Alzheimer’s drug, along with its high price, is now being investigated by two House committees.
“We have serious concerns about the…
Source: Topamax